Thanks for the posts. IMO,The market clearly responded to the Cotara update. Have read your previous posts and this portion of one of your posts stands out.
I don't think anyone knows how effective Cotara can be in treating any and all solid tumors ( maybe the Chinese do ). I understand that trials need parameters but keep in mind that Cotara becomes more effective with each dose. It also has several advantages over Bavi: 1) It does not depend on the immune system for efficacy. 2) Even though Bavi can destroy tumor vasculature the tumor may still feed off the tissue near its periphery ---Cotara destroys tumors from the inside out. 3) Cotara has been approved for phase 3( albeit a different mode of delivery ) 4) Cotara hasd been approved for "Orphan Drug and Fast Track " status.
Of course Cotara has radiation complications that Bavi doesn't but the focus should be on the possible synergestic effects achieveable when all of Tustin's tech is used together. One last comment---I don't know how culpable Dr. Epstein is , but I would be fuming if my lifes work was in Tustin's hands---I HOPE Dr. Thorpe does not become disenchanted.